纽约 - 专注于开发脑健康疾病治疗方法的生物制药公司Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)被选入纳斯达克生物技术指数 (NBI)。该公司将于2024年12月23日开盘时正式纳入指数。目前,该公司市值约5.3亿美元,根据 InvestingPro 分析,其财务健康状况获得FAIR评级。
Bio-Techne Corporation , a leader in automated platforms for biotherapeutic characterization, today announced a co-marketing and co-promotion agreement with Waters Corporation aimed at expanding the ...
Nuvalent, Inc. , a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Shutdown Grows Closer as Trump Tells G.O.P. to Kill Spending Deal The bill Republicans and Democrats agreed on is in jeopardy after President-elect Trump condemned it three days before the ...
On Thursday Greece is set to return to Turkey 1,055 ancient Lydian coins, seized by the Greek authorities, a move that highlights the increased cooperation between the two countries in fighting ...
December 19, 2024 • The International Brotherhood of Teamsters said workers in Atlanta, New York City, California and Illinois plan to join the picket line.
EXCLUSIVETrail of Google Street View clues that snared a killer: A mystery figure with a wheelbarrow, a 'body' getting stuffed in a car boot... the astonishing train of events that could solve a ...